{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T08:24:10Z","timestamp":1794126250534,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77238-0","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:34:17Z","timestamp":1787841257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psilocybin enhances sociability only in altered behavioural state and does not need an awake experience to be effective"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-6431","authenticated-orcid":false,"given":"Chenchen","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2650-803X","authenticated-orcid":false,"given":"Tinya","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Buchborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5718-0765","authenticated-orcid":false,"given":"Thomas","family":"Kn\u00f6pfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"77238_CR1","doi-asserted-by":"publisher","unstructured":"Siegel, J. S., Liston, C., Nicol, G. E., Carhart-Harris, R. L. & Bogenschutz, M. P. The science of psychedelic medicine. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-04194-5 (2026).","DOI":"10.1038\/s41591-025-04194-5"},{"key":"77238_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","volume":"632","author":"JS Siegel","year":"2024","unstructured":"Siegel, J. S. et al. Psilocybin desynchronizes the human brain. Nature 632, 131\u2013138 (2024).","journal-title":"Nature"},{"key":"77238_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin, G. M. et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N. Engl. J. Med. 387, 1637\u20131648 (2022).","journal-title":"N. Engl. J. Med."},{"key":"77238_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths, R. R. et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J. Psychopharmacol. Oxf. Engl. 30, 1181\u20131197 (2016).","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"77238_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s00213-006-0458-4","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths, R. R., Richards, W. A., McCann, U. & Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187, 284\u2013292 (2006).","journal-title":"Psychopharmacology"},{"key":"77238_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-025-08813-6","volume":"642","author":"L-X Shao","year":"2025","unstructured":"Shao, L.-X. et al. Psilocybin\u2019s lasting action requires pyramidal cell types and 5-HT2A receptors. Nature 642, 411\u2013420 (2025).","journal-title":"Nature"},{"key":"77238_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2025.11.009","volume":"189","author":"Q Jiang","year":"2026","unstructured":"Jiang, Q. et al. Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks. Cell 189, 659\u2013675.e22 (2026).","journal-title":"Cell"},{"key":"77238_CR8","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41593-025-02068-0","volume":"28","author":"A Hammo","year":"2025","unstructured":"Hammo, A., Wisser, S. & Cichon, J. Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain. Nat. Neurosci. 28, 2285\u20132295 (2025).","journal-title":"Nat. Neurosci."},{"key":"77238_CR9","doi-asserted-by":"publisher","unstructured":"Mollinedo-Gajate, I. et al. Psilocybin Rescues Sociability Deficits in an Animal Model of Autism https:\/\/doi.org\/10.1101\/2020.09.09.289348 (2020).","DOI":"10.1101\/2020.09.09.289348"},{"key":"77238_CR10","doi-asserted-by":"publisher","first-page":"110202","DOI":"10.1016\/j.neuropharm.2024.110202","volume":"262","author":"JJ Gattuso","year":"2025","unstructured":"Gattuso, J. J., Wilson, C., Hannan, A. J. & Renoir, T. Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviour. Neuropharmacology 262, 110202 (2025).","journal-title":"Neuropharmacology"},{"key":"77238_CR11","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1021\/acschemneuro.4c00279","volume":"15","author":"SC Woodburn","year":"2024","unstructured":"Woodburn, S. C., Levitt, C. M., Koester, A. M. & Kwan, A. C. Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors. ACS Chem. Neurosci. 15, 3034\u20133043 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"77238_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/2045125316638008","volume":"6","author":"RG Dos Santos","year":"2016","unstructured":"Dos Santos, R. G. et al. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther. Adv. Psychopharmacol. 6, 193\u2013213 (2016).","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"77238_CR13","doi-asserted-by":"publisher","first-page":"115886","DOI":"10.1016\/j.psychres.2024.115886","volume":"335","author":"Y Yao","year":"2024","unstructured":"Yao, Y. et al. Efficacy and safety of psychedelics for the treatment of mental disorders: a systematic review and meta-analysis. Psychiatry Res. 335, 115886 (2024).","journal-title":"Psychiatry Res."},{"key":"77238_CR14","doi-asserted-by":"publisher","first-page":"120332","DOI":"10.1016\/j.jns.2022.120332","volume":"440","author":"SC da Costa","year":"2022","unstructured":"da Costa, S. C., Oesterle, T., Rummans, T. A., Richelson, E. & Gold, M. Psychedelic drugs for psychiatric disorders. J. Neurol. Sci. 440, 120332 (2022).","journal-title":"J. Neurol. Sci."},{"key":"77238_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris, R. L. et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology 235, 399\u2013408 (2018).","journal-title":"Psychopharmacology"},{"key":"77238_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1134454","volume":"14","author":"PB van der Meer","year":"2023","unstructured":"van der Meer, P. B. et al. Therapeutic effect of psilocybin in addiction: a systematic review. Front. Psychiatry 14, 1134454 (2023).","journal-title":"Front. Psychiatry"},{"key":"77238_CR17","doi-asserted-by":"publisher","first-page":"pyae057","DOI":"10.1093\/ijnp\/pyae057","volume":"27","author":"HM Collins","year":"2024","unstructured":"Collins, H. M. Psychedelics for the treatment of obsessive-compulsive disorder: efficacy and proposed mechanisms. Int. J. Neuropsychopharmacol. 27, pyae057 (2024).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"77238_CR18","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","volume":"29","author":"SK Peck","year":"2023","unstructured":"Peck, S. K. et al. Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nat. Med. 29, 1947\u20131953 (2023).","journal-title":"Nat. Med."},{"key":"77238_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s44184-023-00053-8","volume":"3","author":"KV Bhatt","year":"2024","unstructured":"Bhatt, K. V. & Weissman, C. R. The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects. Npj Ment. Health Res. 3, 7 (2024).","journal-title":"Npj Ment. Health Res."},{"key":"77238_CR20","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1038\/s41380-024-02875-0","volume":"30","author":"J Jungwirth","year":"2025","unstructured":"Jungwirth, J., von Rotz, R., Dziobek, I., Vollenweider, F. X. & Preller, K. H. Psilocybin increases emotional empathy in patients with major depression. Mol. Psychiatry 30, 2665\u20132672 (2025).","journal-title":"Mol. Psychiatry"},{"key":"77238_CR21","doi-asserted-by":"publisher","unstructured":"Prislin, R. & Crano, W. D. Sociability. In The Psychology of Sociability 36\u201356 https:\/\/doi.org\/10.4324\/9781003258582-4.(Routledge, New York, 2022).","DOI":"10.4324\/9781003258582-4"},{"key":"77238_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0149-7634(83)90035-0","volume":"7","author":"GD Wills","year":"1983","unstructured":"Wills, G. D., Wesley, A. L., Moore, F. R. & Sisemore, D. A. Social interactions among rodent conspecifics: a review of experimental paradigms. Neurosci. Biobehav. Rev. 7, 315\u2013323 (1983).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"77238_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1601-183X.2005.00123.x","volume":"4","author":"CM Spencer","year":"2005","unstructured":"Spencer, C. M., Alekseyenko, O., Serysheva, E., Yuva-Paylor, L. A. & Paylor, R. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav. 4, 420\u2013430 (2005).","journal-title":"Genes Brain Behav."},{"key":"77238_CR24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41593-018-0110-8","volume":"21","author":"L Qin","year":"2018","unstructured":"Qin, L. et al. Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition. Nat. Neurosci. 21, 564\u2013575 (2018).","journal-title":"Nat. Neurosci."},{"key":"77238_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","volume":"147","author":"O Pe\u00f1agarikano","year":"2011","unstructured":"Pe\u00f1agarikano, O. et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147, 235\u2013246 (2011).","journal-title":"Cell"},{"key":"77238_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.euroneuro.2014.03.008","volume":"24","author":"MJ Millan","year":"2014","unstructured":"Millan, M. J., Fone, K., Steckler, T. & Horan, W. P. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 24, 645\u2013692 (2014).","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"77238_CR27","first-page":"100631","volume":"14","author":"A Kupferberg","year":"2023","unstructured":"Kupferberg, A. & Hasler, G. The social cost of depression: Investigating the impact of impaired social emotion regulation, social cognition, and interpersonal behavior on social functioning. J. Affect. Disord. Rep. 14, 100631 (2023).","journal-title":"J. Affect. Disord. Rep."},{"key":"77238_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrneurol.2015.229","volume":"12","author":"JD Henry","year":"2016","unstructured":"Henry, J. D., von Hippel, W., Molenberghs, P., Lee, T. & Sachdev, P. S. Clinical assessment of social cognitive function in neurological disorders. Nat. Rev. Neurol. 12, 28\u201339 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"77238_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","volume":"78","author":"AK Davis","year":"2021","unstructured":"Davis, A. K. et al. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry 78, 481\u2013489 (2021).","journal-title":"JAMA Psychiatry"},{"key":"77238_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.61373\/pp025r.0002","volume":"1","author":"EJ Brouns","year":"2025","unstructured":"Brouns, E. J., Ekins, T. G. & Ahmed, O. J. Single-dose psychedelic enhances cognitive flexibility and reversal learning in mice weeks after administration. Psychedelics 1, 7 https:\/\/doi.org\/10.61373\/pp025r.0002 (2025).","journal-title":"Psychedelics"},{"key":"77238_CR31","doi-asserted-by":"publisher","unstructured":"Lu, O. D. et al. A multi-institutional investigation of psilocybin\u2019s effects on mouse behavior. BioRxiv Prepr. Serv. Biol. 2025.04.08.647810 https:\/\/doi.org\/10.1101\/2025.04.08.647810 (2025).","DOI":"10.1101\/2025.04.08.647810"},{"key":"77238_CR32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022489118","volume":"118","author":"N Hesselgrave","year":"2021","unstructured":"Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B. & Thompson, S. M. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc. Natl. Acad. Sci. USA 118, e2022489118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77238_CR33","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","volume":"11","author":"M Hibicke","year":"2020","unstructured":"Hibicke, M., Landry, A. N., Kramer, H. M., Talman, Z. K. & Nichols, C. D. Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression. ACS Chem. Neurosci. 11, 864\u2013871 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"77238_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06303-z","volume":"25","author":"J Perna","year":"2025","unstructured":"Perna, J. et al. Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report. BMC Psychiatry 25, 184 (2025).","journal-title":"BMC Psychiatry"},{"key":"77238_CR35","doi-asserted-by":"publisher","unstructured":"Bender, D. A. et al. Provider perspectives on challenges in treatment during psychedelic therapy. Psychopharmacology https:\/\/doi.org\/10.1007\/s00213-025-06907-7 (2025).","DOI":"10.1007\/s00213-025-06907-7"},{"key":"77238_CR36","doi-asserted-by":"publisher","unstructured":"Mertens, L. J. et al. Efficacy and safety of psilocybin in treatment-resistant major depression: the EPISODE randomized clinical trial. JAMA Psychiatry https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.0132 (2026).","DOI":"10.1001\/jamapsychiatry.2026.0132"},{"key":"77238_CR37","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1176\/appi.ajp.22010073","volume":"179","author":"G Barber","year":"2022","unstructured":"Barber, G., Nemeroff, C. B. & Siegel, S. A case of prolonged mania, psychosis, and severe depression after psilocybin use: implications of increased psychedelic drug availability. Am. J. Psychiatry 179, 892\u2013896 (2022).","journal-title":"Am. J. Psychiatry"},{"key":"77238_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamapsychiatry.2024.2546","volume":"81","author":"JT Hinkle","year":"2024","unstructured":"Hinkle, J. T., Graziosi, M., Nayak, S. M. & Yaden, D. B. Adverse events in studies of classic psychedelics: a systematic review and meta-analysis. JAMA Psychiatry 81, 1225\u20131235 (2024).","journal-title":"JAMA Psychiatry"},{"key":"77238_CR39","first-page":"100243","volume":"4","author":"Y Kim","year":"2025","unstructured":"Kim, Y., Bigley, R., DeVinney, A. & Nestadt, P. S. The many faces of psilocybin-related psychosis: a case series. Psychiatry Res. Case Rep. 4, 100243 (2025).","journal-title":"Psychiatry Res. Case Rep."},{"key":"77238_CR40","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.neuropharm.2019.107933","volume":"167","author":"AL Halberstadt","year":"2020","unstructured":"Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J. & Brandt, S. D. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology 167, 107933 (2020).","journal-title":"Neuropharmacology"},{"key":"77238_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44016-1","volume":"14","author":"J Wallach","year":"2023","unstructured":"Wallach, J. et al. Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential. Nat. Commun. 14, 8221 (2023).","journal-title":"Nat. Commun."},{"key":"77238_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.abl8615","volume":"375","author":"D Cao","year":"2022","unstructured":"Cao, D. et al. Structure-based discovery of nonhallucinogenic psychedelic analogs. Science 375, 403\u2013411 (2022).","journal-title":"Science"},{"key":"77238_CR43","doi-asserted-by":"publisher","unstructured":"Aarrestad, I. K. et al. The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-025-02021-1 (2025).","DOI":"10.1038\/s41593-025-02021-1"},{"key":"77238_CR44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","volume":"589","author":"LP Cameron","year":"2021","unstructured":"Cameron, L. P. et al. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature 589, 474\u2013479 (2021).","journal-title":"Nature"},{"key":"77238_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02039-0","volume":"12","author":"F Cavanna","year":"2022","unstructured":"Cavanna, F. et al. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Transl. Psychiatry 12, 307 (2022).","journal-title":"Transl. Psychiatry"},{"key":"77238_CR46","doi-asserted-by":"publisher","first-page":"102600","DOI":"10.1016\/j.drugpo.2019.11.008","volume":"75","author":"T Lea","year":"2020","unstructured":"Lea, T., Amada, N., Jungaberle, H., Schecke, H. & Klein, M. Microdosing psychedelics: motivations, subjective effects and harm reduction. Int. J. Drug Policy 75, 102600 (2020).","journal-title":"Int. J. Drug Policy"},{"key":"77238_CR47","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","volume":"4","author":"DB Yaden","year":"2021","unstructured":"Yaden, D. B. & Griffiths, R. R. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol. Transl. Sci. 4, 568\u2013572 (2021).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"77238_CR48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","volume":"4","author":"DE Olson","year":"2021","unstructured":"Olson, D. E. The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharmacol. Transl. Sci. 4, 563\u2013567 (2021).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"77238_CR49","doi-asserted-by":"publisher","first-page":"eadw4682","DOI":"10.1126\/sciadv.adw4682","volume":"11","author":"S-S Jang","year":"2025","unstructured":"Jang, S.-S., Takahashi, F. & Huguenard, J. R. Reticular thalamic hyperexcitability drives autism spectrum disorder behaviors in the Cntnap2 model of autism. Sci. Adv. 11, eadw4682 (2025).","journal-title":"Sci. Adv."},{"key":"77238_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah6733","volume":"9","author":"A Selimbeyoglu","year":"2017","unstructured":"Selimbeyoglu, A. et al. Modulation of prefrontal cortex excitation\/inhibition balance rescues social behavior in CNTNAP2-deficient mice. Sci. Transl. Med. 9, eaah6733 (2017).","journal-title":"Sci. Transl. Med."},{"key":"77238_CR51","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJMoa052773","volume":"354","author":"KA Strauss","year":"2006","unstructured":"Strauss, K. A. et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 354, 1370\u20131377 (2006).","journal-title":"N. Engl. J. Med."},{"key":"77238_CR52","doi-asserted-by":"publisher","unstructured":"Cording, K. R., Tu, E. M., Wang, H., Agopyan-Miu, A. H. C. W. & Bateup, H. S. Cntnap2 loss drives striatal neuron hyperexcitability and behavioral inflexibility. BioRxiv Prepr. Serv. Biol. 2024.05.09.593387 https:\/\/doi.org\/10.1101\/2024.05.09.593387 (2024).","DOI":"10.1101\/2024.05.09.593387"},{"key":"77238_CR53","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen, M. K. et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacol. Publ. Am. Coll. Neuropsychopharmacol. 44, 1328\u20131334 (2019).","journal-title":"Neuropsychopharmacol. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"77238_CR54","doi-asserted-by":"publisher","unstructured":"Chiu, Y.-T. et al. A suite of engineered mice for interrogating psychedelic drug actions. BioRxiv Prepr. Serv. Biol. 2023.09.25.559347 https:\/\/doi.org\/10.1101\/2023.09.25.559347 (2023).","DOI":"10.1101\/2023.09.25.559347"},{"key":"77238_CR55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonz\u00e1lez-Maeso","year":"2007","unstructured":"Gonz\u00e1lez-Maeso, J. et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53, 439\u2013452 (2007).","journal-title":"Neuron"},{"key":"77238_CR56","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1021\/acsptsci.3c00123","volume":"6","author":"NT Jones","year":"2023","unstructured":"Jones, N. T. et al. Transient elevation of plasma glucocorticoids supports psilocybin-induced anxiolysis in mice. ACS Pharmacol. Transl. Sci. 6, 1221\u20131231 (2023).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"77238_CR57","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1021\/acs.jmedchem.9b01404","volume":"63","author":"LE Dunlap","year":"2020","unstructured":"Dunlap, L. E. et al. Identification of psychoplastogenic N,N-dimethylaminoisotryptamine (isoDMT) analogues through structure-activity relationship studies. J. Med. Chem. 63, 1142\u20131155 (2020).","journal-title":"J. Med. Chem."},{"key":"77238_CR58","doi-asserted-by":"publisher","first-page":"136836","DOI":"10.1016\/j.neulet.2022.136836","volume":"788","author":"AM Jaster","year":"2022","unstructured":"Jaster, A. M. et al. Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL\/6J mice. Neurosci. Lett. 788, 136836 (2022).","journal-title":"Neurosci. Lett."},{"key":"77238_CR59","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"L-X Shao","year":"2021","unstructured":"Shao, L.-X. et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 109, 2535\u20132544.e4 (2021).","journal-title":"Neuron"},{"key":"77238_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab260","volume":"45","author":"B Geuther","year":"2022","unstructured":"Geuther, B. et al. High-throughput visual assessment of sleep stages in mice using machine learning. Sleep 45, zsab260 (2022).","journal-title":"Sleep"},{"key":"77238_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30422-9","volume":"8","author":"C Song","year":"2018","unstructured":"Song, C., Piscopo, D. M., Niell, C. M. & Kn\u00f6pfel, T. Cortical signatures of wakeful somatosensory processing. Sci. Rep. 8, 11977 (2018).","journal-title":"Sci. Rep."},{"key":"77238_CR62","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41592-024-02375-7","volume":"21","author":"R Zhang","year":"2024","unstructured":"Zhang, R. et al. Rapid, biochemical tagging of cellular activity history in vivo. Nat. Methods 21, 1725\u20131735 (2024).","journal-title":"Nat. Methods"},{"key":"77238_CR63","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/npp.2017.84","volume":"42","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris, R. L. & Goodwin, G. M. The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacol. Publ. Am. Coll. Neuropsychopharmacol. 42, 2105\u20132113 (2017).","journal-title":"Neuropsychopharmacol. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"77238_CR64","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1038\/s41596-020-0382-9","volume":"15","author":"B Rein","year":"2020","unstructured":"Rein, B., Ma, K. & Yan, Z. A standardized social preference protocol for measuring social deficits in mouse models of autism. Nat. Protoc. 15, 3464\u20133477 (2020).","journal-title":"Nat. Protoc."},{"key":"77238_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-022-00521-6","volume":"13","author":"R Jabarin","year":"2022","unstructured":"Jabarin, R., Netser, S. & Wagner, S. Beyond the three-chamber test: toward a multimodal and objective assessment of social behavior in rodents. Mol. Autism 13, 41 (2022).","journal-title":"Mol. Autism"},{"key":"77238_CR66","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","volume":"21","author":"A Mathis","year":"2018","unstructured":"Mathis, A. et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat. Neurosci. 21, 1281\u20131289 (2018).","journal-title":"Nat. Neurosci."},{"key":"77238_CR67","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41596-019-0176-0","volume":"14","author":"T Nath","year":"2019","unstructured":"Nath, T. et al. Using deepLabCut for 3D markerless pose estimation across species and behaviors. Nat. Protoc. 14, 2152\u20132176 (2019).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77238-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:55:41Z","timestamp":1790549741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77238-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77238"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77238-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10268"}}